GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Fibrosarcoma is a malignant soft tissue sarcoma with limited treatment options.
• Polypeptide N-acetylgalactosaminyltransferase 12 (GALNT12) is implicated in tumor progression, notably in colorectal cancer.
• The role of GALNT12 in fibrosarcoma remains largely unexplored.

Purpose of the Study:

• To investigate the expression and biological function of GALNT12 in fibrosarcoma.
• To determine if GALNT12 expression correlates with fibrosarcoma patient prognosis.
• To elucidate the molecular mechanisms underlying GALNT12's role in fibrosarcoma progression.

Main Methods:

• Analysis of patient data and public datasets (GSE24369, GSE21124).
• Assessment of GALNT12 expression using immunofluorescence, RT-qPCR, Western blotting, and immunohistochemistry.
• In vitro functional assays (proliferation, migration) using HT-1080 cells with GALNT12 knockdown via small interfering RNA.
• Gene set enrichment analysis to identify associated signaling pathways.

Main Results:

• GALNT12 expression was significantly upregulated in fibrosarcoma cell lines and tissues, correlating with poor patient prognosis.
• High GALNT12 expression enhanced fibrosarcoma cell proliferation and migration in vitro.
• GALNT12 expression was associated with the YAP1 signaling pathway; GALNT12 knockdown inhibited YAP1 nuclear translocation and downstream gene activation (AMOTL2, BIRC5, CYR61).

Conclusions:

• GALNT12 promotes fibrosarcoma progression by enhancing cell proliferation and migration.
• GALNT12 may serve as a potential prognostic biomarker for fibrosarcoma.
• Targeting GALNT12 presents a potential therapeutic strategy for fibrosarcoma.